Lind Global Fund II LP - 31 Dec 2024 SCHEDULE 13G/A Report for NLS Pharmaceuticals Ltd. Common Shares, par value CHF 0.02 per share (NLSP)

Filing Manager
Lind Global Fund II LP
Reporting Manager
Lind Global Fund II LP
Security
NLS Pharmaceuticals Ltd. Common Shares, par value CHF 0.02 per share
Symbol
NLSP
Shares outstanding
1,220,000 shares
Disclosed Ownership
59,780 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:08:56 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund II LP 4.9% 59,780 59,780 0 By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners II LLC 4.9% 59,780 59,780 0 /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 4.9% 59,780 59,780 0 /s/ Jeff Easton Jeff Easton